Dr Alan Bilsland

  • Honorary Lecturer, Affiliate (School of Cancer Sciences)

email: Alan.Bilsland@glasgow.ac.uk

314 Level 3,, Wolfson Wohl Cancer Res. Centre,, G61 1qh

Import to contacts

ORCID iDhttps://orcid.org/0000-0003-0957-3908

Publications

List by: Type | Date

Jump to: 2023 | 2021 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000
Number of items: 42.

2023

Seitz, Judith, Bilsland, Alan ORCID logoORCID: https://orcid.org/0000-0003-0957-3908, Puget, Chloé, Baasner, Ian, Klopfleisch, Robert and Stein, Torsten (2023) SFRP1 expression is inversely associated with metastasis formation in canine mammary tumours. Journal of Mammary Gland Biology and Neoplasia, 28(1), p. 15. (doi: 10.1007/s10911-023-09543-z) (PMID:37402051)

2021

Ibrahim, Ayman, Bilsland, Alan ORCID logoORCID: https://orcid.org/0000-0003-0957-3908, Rickelt, Steffen, Morris, Joanna ORCID logoORCID: https://orcid.org/0000-0001-5975-2475 and Stein, Torsten ORCID logoORCID: https://orcid.org/0000-0002-9946-1549 (2021) A matrisome RNA signature from early-pregnancy mouse mammary fibroblasts predicts distant metastasis-free breast cancer survival in humans. Breast Cancer Research, 23, 90. (doi: 10.1186/s13058-021-01470-3) (PMID:34565423) (PMCID:PMC8474794)

2019

Bilsland, Alan E. ORCID logoORCID: https://orcid.org/0000-0003-0957-3908, Liu, Yu, Turnbull, Andrew, Sumpton, David, Stevenson, Katrina, Cairney, Claire J., Boyd, Susan M., Roffey, Jon, Jenkinson, David and Keith, W. Nicol ORCID logoORCID: https://orcid.org/0000-0001-7862-3580 (2019) A novel pyrazolopyrimidine ligand of human PGK1 and stress sensor DJ1 modulates the shelterin complex and telomere length regulation. Neoplasia, 21(9), pp. 893-907. (doi: 10.1016/j.neo.2019.07.008) (PMID:31401411) (PMCID:PMC6700475)

2018

Bilsland, Alan ORCID logoORCID: https://orcid.org/0000-0003-0957-3908, Kelly, Caroline ORCID logoORCID: https://orcid.org/0000-0002-5330-7888, Roccisana, Jennifer, Paul, James ORCID logoORCID: https://orcid.org/0000-0001-7367-5816, Jones, Robert ORCID logoORCID: https://orcid.org/0000-0002-2904-6980, Edwards, Joanne ORCID logoORCID: https://orcid.org/0000-0002-7192-6906, Roseweir, Antonia ORCID logoORCID: https://orcid.org/0000-0001-6158-1564, Stein, Torsten ORCID logoORCID: https://orcid.org/0000-0002-9946-1549 and West, Katherine ORCID logoORCID: https://orcid.org/0000-0002-5994-8969 (2018) An Exploratory Study on the Use of Game-based Learning Using Microsoft Kinect to Teach Oncology Phase I Clinical Trial Designs. 2018 NCRI Cancer Conference, Glasgow, UK, 04-06 Nov 2018. (doi: 10.1038/s41416-018-0299-z)

2017

Cairney, C. J. et al. (2017) A 'synthetic-sickness' screen for senescence re-engagement targets in mutant cancer backgrounds. PLoS Genetics, 13(8), e1006942. (doi: 10.1371/journal.pgen.1006942) (PMID:28806777) (PMCID:PMC5570495)

2016

Bilsland, Alan E. ORCID logoORCID: https://orcid.org/0000-0003-0957-3908, Spiliopoulou, Pavlina ORCID logoORCID: https://orcid.org/0000-0002-6486-6319 and Evans, T.R. Jeffry ORCID logoORCID: https://orcid.org/0000-0002-4175-914X (2016) Virotherapy: cancer gene therapy at last? F1000Research, 5, 2105. (doi: 10.12688/f1000research.8211.1) (PMID:27635234) (PMCID:PMC5007754)

Ali, A. et al. (2016) Investigating various thresholds as immunohistochemistry cutoffs for observer agreement. Applied Immunohistochemistry and Molecular Morphology, 25(9), pp. 599-608. (doi: 10.1097/PAI.0000000000000357) (PMID:27093449)

2015

Amin, A.R.M. R. et al. (2015) Evasion of anti-growth signaling: a key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds. Seminars in Cancer Biology, 35, S55-S77. (doi: 10.1016/j.semcancer.2015.02.005) (PMID:25749195) (PMCID:PMC4561219)

Casey, S. C. et al. (2015) Cancer prevention and therapy through the modulation of the tumor microenvironment. Seminars in Cancer Biology, 35, S199-S223. (doi: 10.1016/j.semcancer.2015.02.007) (PMID:25865775) (PMCID:PMC4930000)

Feitelson, M. A. et al. (2015) Sustained proliferation in cancer: mechanisms and novel therapeutic targets. Seminars in Cancer Biology, 35(Suppl), S25-S54. (doi: 10.1016/j.semcancer.2015.02.006) (PMID:25892662) (PMCID:PMC4898971)

Ferguson, L. R. et al. (2015) Genomic instability in human cancer: molecular insights and opportunities for therapeutic attack and prevention through diet and nutrition. Seminars in Cancer Biology, 35(Suppl), S5-S24. (doi: 10.1016/j.semcancer.2015.03.005) (PMID:25869442) (PMCID:PMC4600419)

Mohammad, R. M. et al. (2015) Broad targeting of resistance to apoptosis in cancer. Seminars in Cancer Biology, 35(Suppl.), S78-S103. (doi: 10.1016/j.semcancer.2015.03.001) (PMID:25936818)

Samadi, A. K. et al. (2015) A multi-targeted approach to suppress tumor-promoting inflammation. Seminars in Cancer Biology, 35(Suppl), S151-S184. (doi: 10.1016/j.semcancer.2015.03.006) (PMID:25951989) (PMCID:PMC4635070)

Vinay, D. S. et al. (2015) Immune evasion in cancer: mechanistic basis and therapeutic strategies. Seminars in Cancer Biology, 35(Suppl.), S185-S198. (doi: 10.1016/j.semcancer.2015.03.004) (PMID:25818339)

Wang, Z. et al. (2015) Broad targeting of angiogenesis for cancer prevention and therapy. Seminars in Cancer Biology, 35(Suppl.), S224-S243. (doi: 10.1016/j.semcancer.2015.01.001) (PMID:25600295) (PMCID:PMC4737670)

Yaswen, P. et al. (2015) Therapeutic targeting of replicative immortality. Seminars in Cancer Biology, 35(Supp.), S104-S128. (doi: 10.1016/j.semcancer.2015.03.007) (PMID:25869441) (PMCID:PMC4600408)

Bilsland, A. E. et al. (2015) Identification of a selective G1-phase benzimidazolone inhibitor by a senescence-targeted virtual screen using artificial neural networks. Neoplasia, 17(9), pp. 704-715. (doi: 10.1016/j.neo.2015.08.009) (PMID:26476078) (PMCID:PMC4611071)

Hartmann, Daniel, von Figura, Guido, Song, Zhangfa, Harden, Sharon, Scott, Lucy C, Evans, TR Jeffry ORCID logoORCID: https://orcid.org/0000-0002-4175-914X, Rudolph, Karl Lenhard, Bilsland, Alan E ORCID logoORCID: https://orcid.org/0000-0003-0957-3908 and Keith, W Nicol ORCID logoORCID: https://orcid.org/0000-0001-7862-3580 (2015) PlasmaN-acetyl-glucosaminidase in advanced gastro-intestinal adenocarcinoma correlates with age, stage and outcome. Future Oncology, 11(2), pp. 193-203. (doi: 10.2217/fon.14.166)

2014

Bilsland, Alan E. ORCID logoORCID: https://orcid.org/0000-0003-0957-3908, Stevenson, Katrina, Liu, Yu, Hoare, Stacey, Cairney, Claire J., Roffey, Jon and Keith, W. Nicol ORCID logoORCID: https://orcid.org/0000-0001-7862-3580 (2014) Mathematical model of a telomerase transcriptional regulatory network developed by cell-based screening: analysis of inhibitor effects and telomerase expression mechanisms. PLoS Computational Biology, 10(2), e1003448. (doi: 10.1371/journal.pcbi.1003448) (PMID:24550717) (PMCID:PMC3923661)

2013

Bilsland, Alan E. ORCID logoORCID: https://orcid.org/0000-0003-0957-3908, Revie, John and Keith, W.Nicol ORCID logoORCID: https://orcid.org/0000-0001-7862-3580 (2013) MicroRNA and senescence: the senectome, integration and distributed control. Critical Reviews in Oncogenesis, 18(4), pp. 373-390. (doi: 10.1615/CritRevOncog.2013007197)

2012

Cairney, C.J., Bilsland, A.E. ORCID logoORCID: https://orcid.org/0000-0003-0957-3908, Evans, T.R.J. ORCID logoORCID: https://orcid.org/0000-0002-4175-914X, Roffey, J., Bennett, D.C., Narita, M., Torrance, C. and Keith, W.N. ORCID logoORCID: https://orcid.org/0000-0001-7862-3580 (2012) Cancer cell senescence: a new frontier in drug development. Drug Discovery Today, 17(5-6), pp. 269-276. (doi: 10.1016/j.drudis.2012.01.019)

Keith, W.N. ORCID logoORCID: https://orcid.org/0000-0001-7862-3580, Lafferty-Whyte, K, Cairney, C.J., Zaffaroni, N. and Bilsland, A. ORCID logoORCID: https://orcid.org/0000-0003-0957-3908 (2012) Response to ‘Validating a gene expression signature proposed to differentiate liposarcomas that use different telomere maintenance mechanism. Oncogene, 31(2), pp. 267-268. (doi: 10.1038/onc.2011.374)

2011

Bilsland, A.E. ORCID logoORCID: https://orcid.org/0000-0003-0957-3908, Cairney, C.J. and Keith, W.N. ORCID logoORCID: https://orcid.org/0000-0001-7862-3580 (2011) Targeting the telomere and shelterin complex for cancer therapy: current views and future perspectives. Journal of Cellular and Molecular Medicine, 15(2), pp. 179-186. (doi: 10.1111/j.1582-4934.2010.01253.x)

2010

Lafferty-Whyte, K., Bilsland, A. ORCID logoORCID: https://orcid.org/0000-0003-0957-3908, Hoare, S.F., Burns, S., Zaffaroni, N., Cairney, C.J. and Keith, W.N. ORCID logoORCID: https://orcid.org/0000-0001-7862-3580 (2010) TCEAL7 inhibition of c-Myc activity in alternative lengthening of telomeres regulates hTERT expression. Neoplasia, 12(5), pp. 405-414.

Bilsland, Alan. E. ORCID logoORCID: https://orcid.org/0000-0003-0957-3908 and Keith, W. Nicol ORCID logoORCID: https://orcid.org/0000-0001-7862-3580 (2010) Mining cellular senescence for drug targets. In: Adams, Peter. D. and Sedivy, John M. (eds.) Cellular Senescence and Tumor Suppression. Springer: New York, pp. 235-266. ISBN 9781441910745 (doi: 10.1007/978-1-4419-1075-2_10)

Lafferty-Whyte, K. et al. (2010) Scoring of senescence signalling in multiple human tumour gene expression datasets, identification of a correlation between senescence score and drug toxicity in the NCI60 panel and a pro-inflammatory signature correlating with survival advantage in peritoneal mesothelioma. BMC Genomics, 11(1), p. 532. (doi: 10.1186/1471-2164-11-532)

Stolzenburg, S., Bilsland, A. ORCID logoORCID: https://orcid.org/0000-0003-0957-3908, Keith, W.N. ORCID logoORCID: https://orcid.org/0000-0001-7862-3580 and Rots, M.G. (2010) Modulation of gene expression using zinc finger-based artificial transcription factors. Methods in Molecular Biology, 649(2), pp. 117-132. (doi: 10.1007/978-1-60761-753-2_7)

2009

Lafferty-Whyte, K., Cairney, C.J., Will, M.B., Serakinci, N., Daidone, M.G., Zaffaroni, N., Bilsland, A.E. and Keith, W.N. ORCID logoORCID: https://orcid.org/0000-0001-7862-3580 (2009) A gene expression signature classifying telomerase and ALT immortalization reveals an hTERT regulatory network and suggests a mesenchymal stem cell origin for ALT. Oncogene, 28(43), pp. 3765-3774. (doi: 10.1038/onc.2009.238)

Bilsland, A.E., Hoare, S.F., Stevenson, K.H., Plumb, J.A., Gomez-Roman, N. ORCID logoORCID: https://orcid.org/0000-0002-2325-7517, Cairney, C.J., Burns, S., Lafferty-Whyte, K., Hammonds, T. and Keith, W.N. ORCID logoORCID: https://orcid.org/0000-0001-7862-3580 (2009) Dynamic telomerase gene suppression via network effects of GSK3 inhibition. PLoS ONE, 4(7), e6459. (doi: 10.1371/journal.pone.0006459) (PMID:19649288) (PMCID:PMC2714081)

2008

Keith, W.N. ORCID logoORCID: https://orcid.org/0000-0001-7862-3580 and Bilsland, A.E. (2008) Targeting telomerase: therapeutic options for cancer treatment. In: Rudolph, K.L. (ed.) Telomeres and Telomerase in Aging, Disease, and Cancer: Molecular Mechanisms of Adult Stem Cell Ageing. Springer: Berlin, Germany, pp. 247-283. ISBN 9783540737087 (doi: 10.1007/978-3-540-73709-4_13)

2007

Bilsland, A.E. ORCID logoORCID: https://orcid.org/0000-0003-0957-3908, Merron, A., Vassaux, G. and Keith, W.N. ORCID logoORCID: https://orcid.org/0000-0001-7862-3580 (2007) Modulation of telomerase promoter tumor selectivity in the context of oncolytic adenoviruses. Cancer Research, 67(3), pp. 1299-1307. (doi: 10.1158/0008-5472.CAN-06-3000)

2006

Anderson, C.J., Hoare, S.F., Ashcroft, M., Bilsland, A.E. ORCID logoORCID: https://orcid.org/0000-0003-0957-3908 and Keith, W.N. ORCID logoORCID: https://orcid.org/0000-0001-7862-3580 (2006) Hypoxic regulation of telomerase gene expression by transcriptional and post-transcriptional mechanisms. Oncogene, 25(1), pp. 61-69. (doi: 10.1038/sj.onc.1209011)

2005

Zhao, J., Bilsland, A. ORCID logoORCID: https://orcid.org/0000-0003-0957-3908, Jackson, K. and Keith, W.N. ORCID logoORCID: https://orcid.org/0000-0001-7862-3580 (2005) MDM2 negatively regulates the human telomerase RNA gene promoter. BMC Cancer, 5, 6. (doi: 10.1186/1471-2407-5-6) (PMID:15656906) (PMCID:PMC546012)

Bilsland, A.E. ORCID logoORCID: https://orcid.org/0000-0003-0957-3908, Fletcher-Monaghan, A. and Keith, W.N. ORCID logoORCID: https://orcid.org/0000-0001-7862-3580 (2005) Properties of a telomerase-specific Cre/Lox switch for transcriptionally targeted cancer gene therapy. Neoplasia, 7(11), pp. 1020-1029. (doi: 10.1593/neo.05385)

Dufes, C., Keith, W.N. ORCID logoORCID: https://orcid.org/0000-0001-7862-3580, Proutski, I., Bilsland, A. ORCID logoORCID: https://orcid.org/0000-0003-0957-3908, Uchegbu, I.F. and Schõtzlein, A.G. (2005) Synthetic anti-cancer gene medicine exploits intrinsic anti-tumour activity of cationic vector to cure established tumours. Cancer Research, 65(18), pp. 8079-8084. (doi: 10.1158/0008-5472.CAN-04-4402)

2004

Keith, W.N. et al. (2004) A mutation in a functional Sp1 binding site of the telomerase RNA gene (hTERC) promoter in a patient with Paroxysmal Nocturnal Haemoglobinuria. BMC Blood Disorders, 4(3), (doi: 10.1186/1471-2326-4-3)

Keith, WN ORCID logoORCID: https://orcid.org/0000-0001-7862-3580, Bilsland, A ORCID logoORCID: https://orcid.org/0000-0003-0957-3908, Hardie, M and Evans, TRJ ORCID logoORCID: https://orcid.org/0000-0002-4175-914X (2004) Drug Insight: cancer cell immortality - telomerase as a target for novel cancer gene therapies. Nature Clinical Practice Oncology, 1(2), pp. 88-96. (doi: 10.1038/ncponc0044)

2003

Bilsland, A.E. ORCID logoORCID: https://orcid.org/0000-0003-0957-3908, Anderson, C.J., Fletcher-Monaghan, A.J., McGregor, F., Evans, T.R.J. ORCID logoORCID: https://orcid.org/0000-0002-4175-914X, Ganly, I., Knox, R.J., Plumb, J.A. and Keith, W.N. ORCID logoORCID: https://orcid.org/0000-0001-7862-3580 (2003) Selective ablation of human cancer cells by telomerase-specific adenoviral suicide gene therapy vectors expressing bacterial nitroreductase. Oncogene, 22(3), pp. 370-380. (doi: 10.1038/sj.onc.1206168)

Zhao, J.Q., Bilsland, A. ORCID logoORCID: https://orcid.org/0000-0003-0957-3908, Hoare, S.F. and Keith, W.N. ORCID logoORCID: https://orcid.org/0000-0001-7862-3580 (2003) Involvement of NF-Y and Sp1 binding sequences in basal transcription of the human telomerase RNA gene. FEBS Letters, 536(1-3), pp. 111-119. (doi: 10.1016/S0014-5793(03)00038-3)

2002

Keith, W.N. ORCID logoORCID: https://orcid.org/0000-0001-7862-3580, Bilsland, A. ORCID logoORCID: https://orcid.org/0000-0003-0957-3908, Evans, T.R.J. ORCID logoORCID: https://orcid.org/0000-0002-4175-914X and Glasspool, R.M. (2002) Telomerase-Directed Molecular Therapeutics. Expert Reviews in Molecular Medicine(4), pp. 1-25. (doi: 10.1017/S1462399402004507)

2001

Plumb, J.A., Bilsland, A. ORCID logoORCID: https://orcid.org/0000-0003-0957-3908, Kakani, R., Zhao, J.Q., Glasspool, R.M., Knox, R.J., Evans, T.R.J. ORCID logoORCID: https://orcid.org/0000-0002-4175-914X and Keith, W.N. ORCID logoORCID: https://orcid.org/0000-0001-7862-3580 (2001) Telomerase-specific suicide gene therapy vectors expressing bacterial nitroreductase sensitize human cancer cells to the pro-drug CB1954. Oncogene, 20(53), pp. 7797-7803.

2000

Zhao, J.Q., Glasspool, R.M., Hoare, S.F., Bilsland, A. ORCID logoORCID: https://orcid.org/0000-0003-0957-3908, Szatmari, I. and Keith, W.N. ORCID logoORCID: https://orcid.org/0000-0001-7862-3580 (2000) Activation of telomerase RNA gene promoter activity by NF-Y, Sp1, and the retinoblastoma protein and repression by Sp3. Neoplasia, 2(6), pp. 531-539.

This list was generated on Mon Jun 30 12:41:13 2025 BST.
Jump to: Articles | Book Sections | Conference or Workshop Item
Number of items: 42.

Articles

Seitz, Judith, Bilsland, Alan ORCID logoORCID: https://orcid.org/0000-0003-0957-3908, Puget, Chloé, Baasner, Ian, Klopfleisch, Robert and Stein, Torsten (2023) SFRP1 expression is inversely associated with metastasis formation in canine mammary tumours. Journal of Mammary Gland Biology and Neoplasia, 28(1), p. 15. (doi: 10.1007/s10911-023-09543-z) (PMID:37402051)

Ibrahim, Ayman, Bilsland, Alan ORCID logoORCID: https://orcid.org/0000-0003-0957-3908, Rickelt, Steffen, Morris, Joanna ORCID logoORCID: https://orcid.org/0000-0001-5975-2475 and Stein, Torsten ORCID logoORCID: https://orcid.org/0000-0002-9946-1549 (2021) A matrisome RNA signature from early-pregnancy mouse mammary fibroblasts predicts distant metastasis-free breast cancer survival in humans. Breast Cancer Research, 23, 90. (doi: 10.1186/s13058-021-01470-3) (PMID:34565423) (PMCID:PMC8474794)

Bilsland, Alan E. ORCID logoORCID: https://orcid.org/0000-0003-0957-3908, Liu, Yu, Turnbull, Andrew, Sumpton, David, Stevenson, Katrina, Cairney, Claire J., Boyd, Susan M., Roffey, Jon, Jenkinson, David and Keith, W. Nicol ORCID logoORCID: https://orcid.org/0000-0001-7862-3580 (2019) A novel pyrazolopyrimidine ligand of human PGK1 and stress sensor DJ1 modulates the shelterin complex and telomere length regulation. Neoplasia, 21(9), pp. 893-907. (doi: 10.1016/j.neo.2019.07.008) (PMID:31401411) (PMCID:PMC6700475)

Cairney, C. J. et al. (2017) A 'synthetic-sickness' screen for senescence re-engagement targets in mutant cancer backgrounds. PLoS Genetics, 13(8), e1006942. (doi: 10.1371/journal.pgen.1006942) (PMID:28806777) (PMCID:PMC5570495)

Bilsland, Alan E. ORCID logoORCID: https://orcid.org/0000-0003-0957-3908, Spiliopoulou, Pavlina ORCID logoORCID: https://orcid.org/0000-0002-6486-6319 and Evans, T.R. Jeffry ORCID logoORCID: https://orcid.org/0000-0002-4175-914X (2016) Virotherapy: cancer gene therapy at last? F1000Research, 5, 2105. (doi: 10.12688/f1000research.8211.1) (PMID:27635234) (PMCID:PMC5007754)

Ali, A. et al. (2016) Investigating various thresholds as immunohistochemistry cutoffs for observer agreement. Applied Immunohistochemistry and Molecular Morphology, 25(9), pp. 599-608. (doi: 10.1097/PAI.0000000000000357) (PMID:27093449)

Amin, A.R.M. R. et al. (2015) Evasion of anti-growth signaling: a key step in tumorigenesis and potential target for treatment and prophylaxis by natural compounds. Seminars in Cancer Biology, 35, S55-S77. (doi: 10.1016/j.semcancer.2015.02.005) (PMID:25749195) (PMCID:PMC4561219)

Casey, S. C. et al. (2015) Cancer prevention and therapy through the modulation of the tumor microenvironment. Seminars in Cancer Biology, 35, S199-S223. (doi: 10.1016/j.semcancer.2015.02.007) (PMID:25865775) (PMCID:PMC4930000)

Feitelson, M. A. et al. (2015) Sustained proliferation in cancer: mechanisms and novel therapeutic targets. Seminars in Cancer Biology, 35(Suppl), S25-S54. (doi: 10.1016/j.semcancer.2015.02.006) (PMID:25892662) (PMCID:PMC4898971)

Ferguson, L. R. et al. (2015) Genomic instability in human cancer: molecular insights and opportunities for therapeutic attack and prevention through diet and nutrition. Seminars in Cancer Biology, 35(Suppl), S5-S24. (doi: 10.1016/j.semcancer.2015.03.005) (PMID:25869442) (PMCID:PMC4600419)

Mohammad, R. M. et al. (2015) Broad targeting of resistance to apoptosis in cancer. Seminars in Cancer Biology, 35(Suppl.), S78-S103. (doi: 10.1016/j.semcancer.2015.03.001) (PMID:25936818)

Samadi, A. K. et al. (2015) A multi-targeted approach to suppress tumor-promoting inflammation. Seminars in Cancer Biology, 35(Suppl), S151-S184. (doi: 10.1016/j.semcancer.2015.03.006) (PMID:25951989) (PMCID:PMC4635070)

Vinay, D. S. et al. (2015) Immune evasion in cancer: mechanistic basis and therapeutic strategies. Seminars in Cancer Biology, 35(Suppl.), S185-S198. (doi: 10.1016/j.semcancer.2015.03.004) (PMID:25818339)

Wang, Z. et al. (2015) Broad targeting of angiogenesis for cancer prevention and therapy. Seminars in Cancer Biology, 35(Suppl.), S224-S243. (doi: 10.1016/j.semcancer.2015.01.001) (PMID:25600295) (PMCID:PMC4737670)

Yaswen, P. et al. (2015) Therapeutic targeting of replicative immortality. Seminars in Cancer Biology, 35(Supp.), S104-S128. (doi: 10.1016/j.semcancer.2015.03.007) (PMID:25869441) (PMCID:PMC4600408)

Bilsland, A. E. et al. (2015) Identification of a selective G1-phase benzimidazolone inhibitor by a senescence-targeted virtual screen using artificial neural networks. Neoplasia, 17(9), pp. 704-715. (doi: 10.1016/j.neo.2015.08.009) (PMID:26476078) (PMCID:PMC4611071)

Hartmann, Daniel, von Figura, Guido, Song, Zhangfa, Harden, Sharon, Scott, Lucy C, Evans, TR Jeffry ORCID logoORCID: https://orcid.org/0000-0002-4175-914X, Rudolph, Karl Lenhard, Bilsland, Alan E ORCID logoORCID: https://orcid.org/0000-0003-0957-3908 and Keith, W Nicol ORCID logoORCID: https://orcid.org/0000-0001-7862-3580 (2015) PlasmaN-acetyl-glucosaminidase in advanced gastro-intestinal adenocarcinoma correlates with age, stage and outcome. Future Oncology, 11(2), pp. 193-203. (doi: 10.2217/fon.14.166)

Bilsland, Alan E. ORCID logoORCID: https://orcid.org/0000-0003-0957-3908, Stevenson, Katrina, Liu, Yu, Hoare, Stacey, Cairney, Claire J., Roffey, Jon and Keith, W. Nicol ORCID logoORCID: https://orcid.org/0000-0001-7862-3580 (2014) Mathematical model of a telomerase transcriptional regulatory network developed by cell-based screening: analysis of inhibitor effects and telomerase expression mechanisms. PLoS Computational Biology, 10(2), e1003448. (doi: 10.1371/journal.pcbi.1003448) (PMID:24550717) (PMCID:PMC3923661)

Bilsland, Alan E. ORCID logoORCID: https://orcid.org/0000-0003-0957-3908, Revie, John and Keith, W.Nicol ORCID logoORCID: https://orcid.org/0000-0001-7862-3580 (2013) MicroRNA and senescence: the senectome, integration and distributed control. Critical Reviews in Oncogenesis, 18(4), pp. 373-390. (doi: 10.1615/CritRevOncog.2013007197)

Cairney, C.J., Bilsland, A.E. ORCID logoORCID: https://orcid.org/0000-0003-0957-3908, Evans, T.R.J. ORCID logoORCID: https://orcid.org/0000-0002-4175-914X, Roffey, J., Bennett, D.C., Narita, M., Torrance, C. and Keith, W.N. ORCID logoORCID: https://orcid.org/0000-0001-7862-3580 (2012) Cancer cell senescence: a new frontier in drug development. Drug Discovery Today, 17(5-6), pp. 269-276. (doi: 10.1016/j.drudis.2012.01.019)

Keith, W.N. ORCID logoORCID: https://orcid.org/0000-0001-7862-3580, Lafferty-Whyte, K, Cairney, C.J., Zaffaroni, N. and Bilsland, A. ORCID logoORCID: https://orcid.org/0000-0003-0957-3908 (2012) Response to ‘Validating a gene expression signature proposed to differentiate liposarcomas that use different telomere maintenance mechanism. Oncogene, 31(2), pp. 267-268. (doi: 10.1038/onc.2011.374)

Bilsland, A.E. ORCID logoORCID: https://orcid.org/0000-0003-0957-3908, Cairney, C.J. and Keith, W.N. ORCID logoORCID: https://orcid.org/0000-0001-7862-3580 (2011) Targeting the telomere and shelterin complex for cancer therapy: current views and future perspectives. Journal of Cellular and Molecular Medicine, 15(2), pp. 179-186. (doi: 10.1111/j.1582-4934.2010.01253.x)

Lafferty-Whyte, K., Bilsland, A. ORCID logoORCID: https://orcid.org/0000-0003-0957-3908, Hoare, S.F., Burns, S., Zaffaroni, N., Cairney, C.J. and Keith, W.N. ORCID logoORCID: https://orcid.org/0000-0001-7862-3580 (2010) TCEAL7 inhibition of c-Myc activity in alternative lengthening of telomeres regulates hTERT expression. Neoplasia, 12(5), pp. 405-414.

Lafferty-Whyte, K. et al. (2010) Scoring of senescence signalling in multiple human tumour gene expression datasets, identification of a correlation between senescence score and drug toxicity in the NCI60 panel and a pro-inflammatory signature correlating with survival advantage in peritoneal mesothelioma. BMC Genomics, 11(1), p. 532. (doi: 10.1186/1471-2164-11-532)

Stolzenburg, S., Bilsland, A. ORCID logoORCID: https://orcid.org/0000-0003-0957-3908, Keith, W.N. ORCID logoORCID: https://orcid.org/0000-0001-7862-3580 and Rots, M.G. (2010) Modulation of gene expression using zinc finger-based artificial transcription factors. Methods in Molecular Biology, 649(2), pp. 117-132. (doi: 10.1007/978-1-60761-753-2_7)

Lafferty-Whyte, K., Cairney, C.J., Will, M.B., Serakinci, N., Daidone, M.G., Zaffaroni, N., Bilsland, A.E. and Keith, W.N. ORCID logoORCID: https://orcid.org/0000-0001-7862-3580 (2009) A gene expression signature classifying telomerase and ALT immortalization reveals an hTERT regulatory network and suggests a mesenchymal stem cell origin for ALT. Oncogene, 28(43), pp. 3765-3774. (doi: 10.1038/onc.2009.238)

Bilsland, A.E., Hoare, S.F., Stevenson, K.H., Plumb, J.A., Gomez-Roman, N. ORCID logoORCID: https://orcid.org/0000-0002-2325-7517, Cairney, C.J., Burns, S., Lafferty-Whyte, K., Hammonds, T. and Keith, W.N. ORCID logoORCID: https://orcid.org/0000-0001-7862-3580 (2009) Dynamic telomerase gene suppression via network effects of GSK3 inhibition. PLoS ONE, 4(7), e6459. (doi: 10.1371/journal.pone.0006459) (PMID:19649288) (PMCID:PMC2714081)

Bilsland, A.E. ORCID logoORCID: https://orcid.org/0000-0003-0957-3908, Merron, A., Vassaux, G. and Keith, W.N. ORCID logoORCID: https://orcid.org/0000-0001-7862-3580 (2007) Modulation of telomerase promoter tumor selectivity in the context of oncolytic adenoviruses. Cancer Research, 67(3), pp. 1299-1307. (doi: 10.1158/0008-5472.CAN-06-3000)

Anderson, C.J., Hoare, S.F., Ashcroft, M., Bilsland, A.E. ORCID logoORCID: https://orcid.org/0000-0003-0957-3908 and Keith, W.N. ORCID logoORCID: https://orcid.org/0000-0001-7862-3580 (2006) Hypoxic regulation of telomerase gene expression by transcriptional and post-transcriptional mechanisms. Oncogene, 25(1), pp. 61-69. (doi: 10.1038/sj.onc.1209011)

Zhao, J., Bilsland, A. ORCID logoORCID: https://orcid.org/0000-0003-0957-3908, Jackson, K. and Keith, W.N. ORCID logoORCID: https://orcid.org/0000-0001-7862-3580 (2005) MDM2 negatively regulates the human telomerase RNA gene promoter. BMC Cancer, 5, 6. (doi: 10.1186/1471-2407-5-6) (PMID:15656906) (PMCID:PMC546012)

Bilsland, A.E. ORCID logoORCID: https://orcid.org/0000-0003-0957-3908, Fletcher-Monaghan, A. and Keith, W.N. ORCID logoORCID: https://orcid.org/0000-0001-7862-3580 (2005) Properties of a telomerase-specific Cre/Lox switch for transcriptionally targeted cancer gene therapy. Neoplasia, 7(11), pp. 1020-1029. (doi: 10.1593/neo.05385)

Dufes, C., Keith, W.N. ORCID logoORCID: https://orcid.org/0000-0001-7862-3580, Proutski, I., Bilsland, A. ORCID logoORCID: https://orcid.org/0000-0003-0957-3908, Uchegbu, I.F. and Schõtzlein, A.G. (2005) Synthetic anti-cancer gene medicine exploits intrinsic anti-tumour activity of cationic vector to cure established tumours. Cancer Research, 65(18), pp. 8079-8084. (doi: 10.1158/0008-5472.CAN-04-4402)

Keith, W.N. et al. (2004) A mutation in a functional Sp1 binding site of the telomerase RNA gene (hTERC) promoter in a patient with Paroxysmal Nocturnal Haemoglobinuria. BMC Blood Disorders, 4(3), (doi: 10.1186/1471-2326-4-3)

Keith, WN ORCID logoORCID: https://orcid.org/0000-0001-7862-3580, Bilsland, A ORCID logoORCID: https://orcid.org/0000-0003-0957-3908, Hardie, M and Evans, TRJ ORCID logoORCID: https://orcid.org/0000-0002-4175-914X (2004) Drug Insight: cancer cell immortality - telomerase as a target for novel cancer gene therapies. Nature Clinical Practice Oncology, 1(2), pp. 88-96. (doi: 10.1038/ncponc0044)

Bilsland, A.E. ORCID logoORCID: https://orcid.org/0000-0003-0957-3908, Anderson, C.J., Fletcher-Monaghan, A.J., McGregor, F., Evans, T.R.J. ORCID logoORCID: https://orcid.org/0000-0002-4175-914X, Ganly, I., Knox, R.J., Plumb, J.A. and Keith, W.N. ORCID logoORCID: https://orcid.org/0000-0001-7862-3580 (2003) Selective ablation of human cancer cells by telomerase-specific adenoviral suicide gene therapy vectors expressing bacterial nitroreductase. Oncogene, 22(3), pp. 370-380. (doi: 10.1038/sj.onc.1206168)

Zhao, J.Q., Bilsland, A. ORCID logoORCID: https://orcid.org/0000-0003-0957-3908, Hoare, S.F. and Keith, W.N. ORCID logoORCID: https://orcid.org/0000-0001-7862-3580 (2003) Involvement of NF-Y and Sp1 binding sequences in basal transcription of the human telomerase RNA gene. FEBS Letters, 536(1-3), pp. 111-119. (doi: 10.1016/S0014-5793(03)00038-3)

Keith, W.N. ORCID logoORCID: https://orcid.org/0000-0001-7862-3580, Bilsland, A. ORCID logoORCID: https://orcid.org/0000-0003-0957-3908, Evans, T.R.J. ORCID logoORCID: https://orcid.org/0000-0002-4175-914X and Glasspool, R.M. (2002) Telomerase-Directed Molecular Therapeutics. Expert Reviews in Molecular Medicine(4), pp. 1-25. (doi: 10.1017/S1462399402004507)

Plumb, J.A., Bilsland, A. ORCID logoORCID: https://orcid.org/0000-0003-0957-3908, Kakani, R., Zhao, J.Q., Glasspool, R.M., Knox, R.J., Evans, T.R.J. ORCID logoORCID: https://orcid.org/0000-0002-4175-914X and Keith, W.N. ORCID logoORCID: https://orcid.org/0000-0001-7862-3580 (2001) Telomerase-specific suicide gene therapy vectors expressing bacterial nitroreductase sensitize human cancer cells to the pro-drug CB1954. Oncogene, 20(53), pp. 7797-7803.

Zhao, J.Q., Glasspool, R.M., Hoare, S.F., Bilsland, A. ORCID logoORCID: https://orcid.org/0000-0003-0957-3908, Szatmari, I. and Keith, W.N. ORCID logoORCID: https://orcid.org/0000-0001-7862-3580 (2000) Activation of telomerase RNA gene promoter activity by NF-Y, Sp1, and the retinoblastoma protein and repression by Sp3. Neoplasia, 2(6), pp. 531-539.

Book Sections

Bilsland, Alan. E. ORCID logoORCID: https://orcid.org/0000-0003-0957-3908 and Keith, W. Nicol ORCID logoORCID: https://orcid.org/0000-0001-7862-3580 (2010) Mining cellular senescence for drug targets. In: Adams, Peter. D. and Sedivy, John M. (eds.) Cellular Senescence and Tumor Suppression. Springer: New York, pp. 235-266. ISBN 9781441910745 (doi: 10.1007/978-1-4419-1075-2_10)

Keith, W.N. ORCID logoORCID: https://orcid.org/0000-0001-7862-3580 and Bilsland, A.E. (2008) Targeting telomerase: therapeutic options for cancer treatment. In: Rudolph, K.L. (ed.) Telomeres and Telomerase in Aging, Disease, and Cancer: Molecular Mechanisms of Adult Stem Cell Ageing. Springer: Berlin, Germany, pp. 247-283. ISBN 9783540737087 (doi: 10.1007/978-3-540-73709-4_13)

Conference or Workshop Item

Bilsland, Alan ORCID logoORCID: https://orcid.org/0000-0003-0957-3908, Kelly, Caroline ORCID logoORCID: https://orcid.org/0000-0002-5330-7888, Roccisana, Jennifer, Paul, James ORCID logoORCID: https://orcid.org/0000-0001-7367-5816, Jones, Robert ORCID logoORCID: https://orcid.org/0000-0002-2904-6980, Edwards, Joanne ORCID logoORCID: https://orcid.org/0000-0002-7192-6906, Roseweir, Antonia ORCID logoORCID: https://orcid.org/0000-0001-6158-1564, Stein, Torsten ORCID logoORCID: https://orcid.org/0000-0002-9946-1549 and West, Katherine ORCID logoORCID: https://orcid.org/0000-0002-5994-8969 (2018) An Exploratory Study on the Use of Game-based Learning Using Microsoft Kinect to Teach Oncology Phase I Clinical Trial Designs. 2018 NCRI Cancer Conference, Glasgow, UK, 04-06 Nov 2018. (doi: 10.1038/s41416-018-0299-z)

This list was generated on Mon Jun 30 12:41:13 2025 BST.

Research datasets

Jump to: 2019 | 2018 | 2017 | 2015 | 2013 | 2010
Number of items: 13.

2019

Bilsland, A. , Boyd, S., Turnbull, A., Jenkinson, D., Roffey, J. and Keith, N. (2019) Theoretical model of complex between phosphoglycerate kinase 1 and DJ1. [Data Collection]

Ross, K., Keith, N. , Aitchison, I., Allbutt, E., Banks, E., Basra, S., Bilsland, A., Charalambous, A., Chapal, C., Drummond, M., Dunipace, S., Erridge, A., Fremin-Besombes, M., Glasspool, R., Hamilton, V., Hanna, C. , Herfurth, L., Humpleby, M., Hush, G., Ivanova, Y., Jones, R. , Kaleta-Pyrek, A., Kalt, L., Kantor, M., Karolak, G., Keith, A., Klink, S., Laing, B., Lister, A., Mallon, E., Mccann, E., McLaughlin, R., Merchant, Z., Mozel, A., Mrozek, O., Painter, C., Paul, J. , Paxton, J., Perry, M. , Prendergast, E., Proudfoot, B., Raina, T., Roberts, F., Safrany, S., Scott, J., Sleight, R., Smith, C., Strain, E., Stricevic, M., Svanera, S., Tobias, E. , Vansteenhouse, H., Williams, N. and Zhang, H. (2019) A collaborative approach to exploring the future of Cancer treatment and care in relation to Precision Medicine: A design perspective. [Data Collection]

2018

Sumpton, D., Keith, N. and Bilsland, A. (2018) Identification of novel pyrazolopyrimidine compounds that modulate the shelterin complex and telomere length regulation via phosphoglycerate kinase 1 and stress sensor DJ1. [Data Collection]

Turnbull, A. P., Bilsland, A., Liu, Y., Sumpton, D., Stevenson, K., Cairney, C., Roffey, J., Jenkinson, D. and Keith, N. (2018) PGK1 in complex with CRT0063465 (3-[2-(4-bromophenyl)-5,7-dimethyl-pyrazolo[1,5-a]pyrimidin-6-yl]propanoic acid). [Data Collection]

2017

Keith, N. and Bilsland, A. (2017) Confirmatory assay for modulation of the human telomerase reverse transcriptase promoter in HCT116 cells. [Data Collection]

Keith, N. and Bilsland, A. (2017) Confirmatory dose-response cell survival assay for modulators of telomere damage signalling. [Data Collection]

Keith, N. and Bilsland, A. (2017) Luciferase assay for modulation of the human telomerase RNA component promoter. [Data Collection]

Cairney, C., Godwin, L., Bilsland, A., Burns, S., Stevenson, K., McGarry, L., Revie, J., Moore, J., Wiggans, C., Collinson, R., Mudd, C., Tsonou, E., Sadaie, M., Bennet, D., Narita, M., Torrance, C. and Keith, N. (2017) A ‘synthetic-sickness’ screen for senescence re-engagement targets in mutant cancer backgrounds. [Data Collection]

Keith, N. and Bilsland, A. (2017) Cell survival assay for modulators of telomere damage signalling. [Data Collection]

Keith, N. and Bilsland, A. (2017) Luciferase assay for modulation of the human telomerase reverse transcriptase promoter. [Data Collection]

2015

Bilsland, A., Pugliese, A., Liu, Y., Revie, J., Burns, S., McCormick, C., Cairney, C., Bower, J., Drysdale, M., Narita, M., Sadaie, M. and Keith, N. (2015) Identification of a selective G1-phase benzimidazolone inhibitor by a senescence-targeted virtual screen using artificial neural networks. [Data Collection]

2013

Bilsland, A. (2013) Statespaceminer app. [Data Collection]

2010

Lafferty-Whyte, K., Bilsland, A., Hoare, S., Burns, S., Zaffaroni, N., Cairney, C. and Keith, N. (2010) TCEAL7 Inhibition of c-Myc Activity in Alternative Lengthening of Telomeres Regulates hTERT Expression. [Data Collection]

This list was generated on Mon Jun 30 12:37:25 2025 BST.